64
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: Implications for practice

      review-article
      , PhD, BA, MSc, PgCert LTA, FHEA, RAN a , b , c , d , e , * , , PhD, MSc, BSc, AdvAPD, FHEA a , b , , B App. Sc. Rad Therapy, GradCert b , g , , BExPhysRehab, AEP a , b , , PhD, MCEP, BSc, PG Cert Research, PG Cert Tertiary Ed, AEP a , b , , BTh a , c , , MNP, GradCertCaNurs, BNurs a , b , c , , GCLTHE, DCLSc a , b , , BSc a , b , c , , MBBS,FRACP a , b , h , i , , BA, PG Cert, MSc, RN b , g , , PhD, MPhys, PGCert (PF rehab), BApp Sc(Physio) a , b , , PhD b , f
      Seminars in Oncology Nursing
      Elsevier Inc.
      Cancer care, telehealth, COVID-19, interdisciplinary, nursing, disaster management, coronavirus

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          This literature review aims to explore the role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer care team.

          Data Sources

          Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, and grey literature were searched using Google Scholar up until September 2020.

          Conclusion

          While the safe and effective delivery of cancer care via telehealth requires education and training for healthcare professionals and patients, telehealth has provided a timely solution to the barriers caused by the COVID-19 pandemic on the delivery of interdisciplinary cancer services. Globally, evidence has shown that telehealth in cancer care can leverage an innovative response during the COVID-19 pandemic but may provide a long-lasting solution to enable patients to be treated appropriately in their home environment. Telehealth reduces the travel burden on patients for consultation, affords a timely solution to discuss distressing side effects, initiate interventions, and enable possible treatment additions and/or changes.

          Implications for Nursing Practice

          Global public health disasters pose significant and unique challenges to the provision of necessary services for people affected by cancer. Oncology nurses can provide a central contribution in the delivery of telehealth through transformational leadership across all domains and settings in cancer care. Oncology nurses provide the “hub of cancer care” safely embedded in the interdisciplinary team. Telehealth provides a solution to the current global health crisis but could also benefit the future provision of services and broad reach clinical trials.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: found

          Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Mental Health and the Covid-19 Pandemic

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

              Background Cancer patients are regarded as a highly vulnerable group in the current Coronavirus Disease 2019 (COVID-19) pandemic. To date, the clinical characteristics of COVID-19-infected cancer patients remain largely unknown. Patients and methods In this retrospective cohort study, we included cancer patients with laboratory-confirmed COVID-19 from three designated hospitals in Wuhan, China. Clinical data were collected from medical records from 13 January 2020 to 26 February 2020. Univariate and multivariate analyses were carried out to assess the risk factors associated with severe events defined as a condition requiring admission to an intensive care unit, the use of mechanical ventilation, or death. Results A total of 28 COVID-19-infected cancer patients were included; 17 (60.7%) patients were male. Median (interquartile range) age was 65.0 (56.0–70.0) years. Lung cancer was the most frequent cancer type (n = 7; 25.0%). Eight (28.6%) patients were suspected to have hospital-associated transmission. The following clinical features were shown in our cohort: fever (n = 23, 82.1%), dry cough (n = 22, 81%), and dyspnoea (n = 14, 50.0%), along with lymphopaenia (n = 23, 82.1%), high level of high-sensitivity C-reactive protein (n = 23, 82.1%), anaemia (n = 21, 75.0%), and hypoproteinaemia (n = 25, 89.3%). The common chest computed tomography (CT) findings were ground-glass opacity (n = 21, 75.0%) and patchy consolidation (n = 13, 46.3%). A total of 15 (53.6%) patients had severe events and the mortality rate was 28.6%. If the last antitumour treatment was within 14 days, it significantly increased the risk of developing severe events [hazard ratio (HR) = 4.079, 95% confidence interval (CI) 1.086–15.322, P = 0.037]. Furthermore, patchy consolidation on CT on admission was associated with a higher risk of developing severe events (HR = 5.438, 95% CI 1.498–19.748, P = 0.010). Conclusions Cancer patients show deteriorating conditions and poor outcomes from the COVID-19 infection. It is recommended that cancer patients receiving antitumour treatments should have vigorous screening for COVID-19 infection and should avoid treatments causing immunosuppression or have their dosages decreased in case of COVID-19 coinfection.
                Bookmark

                Author and article information

                Journal
                Semin Oncol Nurs
                Semin Oncol Nurs
                Seminars in Oncology Nursing
                Elsevier Inc.
                0749-2081
                1878-3449
                15 October 2020
                15 October 2020
                : 151090
                Affiliations
                [a ]Faculty of Health, University of Canberra, Bruce ACT, Australia
                [b ]Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, University of Canberra, Bruce ACT, Australia
                [c ]School of Nursing, Midwifery and Public Health, University of Canberra, Bruce ACT, Australia
                [d ]Canberra Health Services & ACT Health, SYNERGY Nursing & Midwifery Research Centre, ACT Health Directorate Level 3, Building 6, Canberra Hospital, Australia
                [e ]Robert Gordon University, Aberdeen, Scotland, UK
                [f ]Menzies Health Institute Queensland, Griffith University
                [g ]ICON Cancer Centre, Canberra, Australia
                [h ]Department of medical oncology, The Canberra Hospital, ACT, Australia
                [i ]Australian National University, Canberra, Australia
                Author notes
                [* ]Corresponding Author: Catherine Paterson, Faculty of Health, University of Canberra, Bruce ACT, Australia.
                Article
                S0749-2081(20)30105-4 151090
                10.1016/j.soncn.2020.151090
                7561334
                33218886
                16838d09-ac5c-46e1-b1d3-2e4feb458607
                © 2020 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                cancer care,telehealth,covid-19,interdisciplinary,nursing,disaster management,coronavirus

                Comments

                Comment on this article